Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000711377-26-000013
Filing Date
2026-08-06
Accepted
2026-08-06 08:16:51
Documents
1
Period of Report
2026-08-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3559
  Complete submission text file 0000711377-26-000013.txt   4927
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address
Nassif Mikheal (Reporting) CIK: 0002082158 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17988 | Film No.: 261246203